Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Vidarstiftelsen | 12,37 | 12,37 | 2020-06-03 |
| Avanza Pension | 6,36 | 6,36 | 2020-03-31 |
| Heli Kurjanen | 4,73 | 4,73 | 2020-06-03 |
| Mika Kurjanen | 3,15 | 3,15 | 2020-06-03 |
| Thord Wilkne | 2,33 | 2,33 | 2020-03-31 |
| Nordnet Pensionsförsäkring | 2,07 | 2,07 | 2020-03-31 |
| Ramin Hossein Khatiri | 1,64 | 1,64 | 2020-03-31 |
| Karl Arne Emanuel Ryberg | 1,59 | 1,59 | 2020-03-31 |
| Dan Markusson | 1,50 | 1,50 | 2019-08-19 |
| Henrik Hahn | 1,36 | 1,36 | 2020-03-31 |
2020-08-17 Delårsrapport 2020-Q2
2020-11-10 Delårsrapport 2020-Q3
2021-02-26 Bokslutskommuniké 2020